Skip to main content
Erschienen in: World Journal of Surgery 7/2005

01.07.2005

Complications with Reconstruction Procedures in Pylorus-preserving Pancreaticoduodenectomy

verfasst von: Masaji Tani, M.D., Manabu Kawai, M.D., Hiroshi Terasawa, M.D., Masaki Ueno, M.D., Takashi Hama, M.D., Seiko Hirono, M.D., Shinomi Ina, M.D., Kazuhisa Uchiyama, M.D., Hiroki Yamaue, M.D.

Erschienen in: World Journal of Surgery | Ausgabe 7/2005

Einloggen, um Zugang zu erhalten

Abstract

This study was conducted retrospectively to examine the efficacy of Traverso reconstruction compared with Billroth I reconstruction after pylorus-preserving pancreaticoduodenectomy, in the prevention of several complications. Pylorus-preserving pancreaticoduodenectomy is an aggressive surgery, and insufficiency of the pancreaticoenterostomy plays an important role in the postoperative progression. However, reports examining the correlation between pancreatic fistula and the type of reconstruction after pylorus-preserving pancreaticoduodenectomy have been limited. Sixty-four patients who underwent pylorus-preserving pancreaticoduodenectomy (33 reconstructed by the Traverso technique and 31 reconstructed by the Billroth I technique) were entered into this study to investigate whether the complications were related to the type of reconstruction procedure employed. Insufficiency of the pancreaticojejunostomy, including major leakage and pancreatic fistula, occurred in 18.2% of the reconstructions by Billroth I and 0% of the reconstructions by Traverso (p < 0.05). In addition, jejunal obstruction by recurrent tumor in the remnant pancreas was observed in 3 patients reconstructed by Billroth I, and required palliative bypass surgery. Reconstruction by the Traverso procedure after pylorus-preserving pancreaticoduodenectomy is a safe surgical method and has an advantage for advanced pancreatic cancer, which has high risk of jejunal obstruction by recurrent tumor in the remnant pancreas.
Literatur
1.
Zurück zum Zitat Klinkenbejil J, van der Schelling G, Hop W. The advantage of pylorus-preserving pancreatoduodenectomy in malignant disease of the pancreas and periampullary region. Ann. Surg. 1992;216:142–145 Klinkenbejil J, van der Schelling G, Hop W. The advantage of pylorus-preserving pancreatoduodenectomy in malignant disease of the pancreas and periampullary region. Ann. Surg. 1992;216:142–145
2.
Zurück zum Zitat Yamaguchi K, Tanaka M, Chijiwa K, et al. Early and late complications of pylorus-preserving pancreatoduodenectomy in Japan 1998. J. Hepatobiliary Pancreat. Surg. 1999;6:303–311CrossRefPubMed Yamaguchi K, Tanaka M, Chijiwa K, et al. Early and late complications of pylorus-preserving pancreatoduodenectomy in Japan 1998. J. Hepatobiliary Pancreat. Surg. 1999;6:303–311CrossRefPubMed
3.
Zurück zum Zitat Roder JD, Stein HJ, Bottcher KA, et al. Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy. Ann. Surg. 1999;229:41–48CrossRefPubMed Roder JD, Stein HJ, Bottcher KA, et al. Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy. Ann. Surg. 1999;229:41–48CrossRefPubMed
4.
Zurück zum Zitat Neoptolemos J, Russell R, Bramhall S, et al. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. Br. J. Surg 1997;84:1370–1376CrossRefPubMed Neoptolemos J, Russell R, Bramhall S, et al. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. Br. J. Surg 1997;84:1370–1376CrossRefPubMed
5.
Zurück zum Zitat Kakita A, Yoshida M, Takahashi T. History of pancreaticojejunostomy in pancreaticoduodenectomy: development of a more reliable anastomosis technique. J. Hepatobiliary Pancreat. Surg. 2001;8:230–237CrossRefPubMed Kakita A, Yoshida M, Takahashi T. History of pancreaticojejunostomy in pancreaticoduodenectomy: development of a more reliable anastomosis technique. J. Hepatobiliary Pancreat. Surg. 2001;8:230–237CrossRefPubMed
6.
Zurück zum Zitat Yeo CJ, Cameron J, Sohn TA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma. Comparison of morbidity and mortality and short-term outcome. Ann. Surg. 1999;229:613–624CrossRefPubMed Yeo CJ, Cameron J, Sohn TA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma. Comparison of morbidity and mortality and short-term outcome. Ann. Surg. 1999;229:613–624CrossRefPubMed
7.
Zurück zum Zitat Sikora S, Posner MC. Management of pancreatic stump following pancreaticoduodenectomy. Br. J. Surg. 1995;82:1590–1597PubMed Sikora S, Posner MC. Management of pancreatic stump following pancreaticoduodenectomy. Br. J. Surg. 1995;82:1590–1597PubMed
8.
Zurück zum Zitat Suzuki Y, Fujino Y, Tanioka Y, et al. Selection of pancreaticojejunostomy techniques according to pancreatic texture and duct size. Arch. Surg. 2002;137:1044–1047CrossRefPubMed Suzuki Y, Fujino Y, Tanioka Y, et al. Selection of pancreaticojejunostomy techniques according to pancreatic texture and duct size. Arch. Surg. 2002;137:1044–1047CrossRefPubMed
9.
Zurück zum Zitat Goei TH, van Berge Henegouwen MI, Slooff MJH, et al. Pylorus-preserving pancreatoduodenectomy: influence of a Billroth I versus a Billroth II type of reconstruction on gastric emptying. Dig. Surg. 2001;18:376–380CrossRefPubMed Goei TH, van Berge Henegouwen MI, Slooff MJH, et al. Pylorus-preserving pancreatoduodenectomy: influence of a Billroth I versus a Billroth II type of reconstruction on gastric emptying. Dig. Surg. 2001;18:376–380CrossRefPubMed
10.
Zurück zum Zitat Ohwada S, Tanahashi Y, Ogawa T, et al. In situ vs ex situ pancreatic duct stents of duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy with Billroth I-type reconstruction. Arch. Surg. 2002;137:1289–1293CrossRefPubMed Ohwada S, Tanahashi Y, Ogawa T, et al. In situ vs ex situ pancreatic duct stents of duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy with Billroth I-type reconstruction. Arch. Surg. 2002;137:1289–1293CrossRefPubMed
11.
Zurück zum Zitat Imanaga H. A new method of pancreaticoduodenectomy designed to preserve liver and pancreatic function. Surgery 1960;47:577–586PubMed Imanaga H. A new method of pancreaticoduodenectomy designed to preserve liver and pancreatic function. Surgery 1960;47:577–586PubMed
12.
Zurück zum Zitat Traverso LW, Longmire WJ. Preservation of the pylorus in pancreaticoduodenectomy. Surg. Gynecol. Obstet. 1978;146:959–962PubMed Traverso LW, Longmire WJ. Preservation of the pylorus in pancreaticoduodenectomy. Surg. Gynecol. Obstet. 1978;146:959–962PubMed
13.
Zurück zum Zitat Whipple A, Parsons W, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Ann. Surg. 1935;102:763–779 Whipple A, Parsons W, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Ann. Surg. 1935;102:763–779
14.
Zurück zum Zitat Yamaue H, Tani M, Onishi H, et al. Locoregional chemotherapy for patients with pancreatic cancer intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection. Pancreas 2002;25:366–372CrossRefPubMed Yamaue H, Tani M, Onishi H, et al. Locoregional chemotherapy for patients with pancreatic cancer intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection. Pancreas 2002;25:366–372CrossRefPubMed
15.
Zurück zum Zitat Yeo CJ, Cameron J, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann. Surg. 1997;226:248–257CrossRefPubMed Yeo CJ, Cameron J, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann. Surg. 1997;226:248–257CrossRefPubMed
16.
Zurück zum Zitat Hishinuma S, Ogata Y, Matsui J, et al. Complications after pylorus-preserving pancreatoduodenectomy with gastrointestinal reconstruction by the Imanaga method. J. Am. Coll. Surg. 1998;186:10–16CrossRefPubMed Hishinuma S, Ogata Y, Matsui J, et al. Complications after pylorus-preserving pancreatoduodenectomy with gastrointestinal reconstruction by the Imanaga method. J. Am. Coll. Surg. 1998;186:10–16CrossRefPubMed
17.
Zurück zum Zitat Green B, Loubeau J, Peoples J, et al. Are pancreatoenteric anastomoses improved by duct-to mucosa suture? Am. J. Surg. 1991;161:45–50CrossRef Green B, Loubeau J, Peoples J, et al. Are pancreatoenteric anastomoses improved by duct-to mucosa suture? Am. J. Surg. 1991;161:45–50CrossRef
18.
Zurück zum Zitat Halloran C, Ghaneh P, Bosonnet L, et al. Complications of pancreatic cancer resection. Dig. Surg. 2002;19:138–146CrossRefPubMed Halloran C, Ghaneh P, Bosonnet L, et al. Complications of pancreatic cancer resection. Dig. Surg. 2002;19:138–146CrossRefPubMed
19.
Zurück zum Zitat Ohtsuka T, Yamaguchi K, Chijiwa K, et al. Quality of life after pylorus-preserving pancreatoduodenectomy. Am. J. Surg. 2001;182:230–236CrossRefPubMed Ohtsuka T, Yamaguchi K, Chijiwa K, et al. Quality of life after pylorus-preserving pancreatoduodenectomy. Am. J. Surg. 2001;182:230–236CrossRefPubMed
20.
Zurück zum Zitat Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Ann. Surg. 2000;232:419–429 Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Ann. Surg. 2000;232:419–429
21.
Zurück zum Zitat Lowy AM, Lee JE, Pisters PWT, et al. Prospective randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann. Surg. 1997;226:632–641CrossRefPubMed Lowy AM, Lee JE, Pisters PWT, et al. Prospective randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann. Surg. 1997;226:632–641CrossRefPubMed
Metadaten
Titel
Complications with Reconstruction Procedures in Pylorus-preserving Pancreaticoduodenectomy
verfasst von
Masaji Tani, M.D.
Manabu Kawai, M.D.
Hiroshi Terasawa, M.D.
Masaki Ueno, M.D.
Takashi Hama, M.D.
Seiko Hirono, M.D.
Shinomi Ina, M.D.
Kazuhisa Uchiyama, M.D.
Hiroki Yamaue, M.D.
Publikationsdatum
01.07.2005
Erschienen in
World Journal of Surgery / Ausgabe 7/2005
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-7697-0

Weitere Artikel der Ausgabe 7/2005

World Journal of Surgery 7/2005 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.